David P. Michelin

Statistics

Publications

Citations

280

H-Index

Active since

2007

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

SWOG Cancer Research Network

Arizona Oncology

The University of Texas MD Anderson Cancer Center

Grand Rapids Community College

David P. Michelin is an author at Roswell Park Comprehensive Cancer Center specializing in ovarian cancer, ovarian cancer treatment, and ovarian cancer pharmacotherapy.

Publications per year

2007–2020

Publications

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)

David S. Alberts, Pengfei Liu, Sharon P. Wilczynski et al. · Gynecologic Oncology · 2007 · 117 citations

Medicine, Gynecology, Oncology +16

Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial

Maurie Markman, James Moon, Sharon P. Wilczynski et al. · Gynecologic Oncology · 2009 · 57 citations · Full text

Medicine, Gynecology, Oncology +17

A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.

Joyce F. Liu, Mark F. Brady, Ursula A. Matulonis et al. · Journal of Clinical Oncology · 2020 · 56 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies

Lydia Usha, Michael W. Sill, Kathleen M. Darcy et al. · Gynecologic Oncology · 2011 · 50 citations

Medicine, Gynecology, Oncology +17

1–4 of 4